Mark H. Mirochnick, MD

Emeritus Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Mark Mirochnick, MD is Emeritus Professor of Pediatrics and a member of the Division of Neonatology at Chobanian and Avedisian School of Medicine/Boston Medical Center. His main research activities involve investigating the pharmacology of HIV and TB drugs in newborns, infants, children and pregnant women. He has served as protocol chair, investigator and/or protocol pharmacologist on many international protocol teams in this area. He currently serves as co-chair of the US Perinatal HIV Guidelines Committee and is a member of the US Pediatric HIV Guidelines Committee and the WHO Pediatric Antiretroviral Working Group.

Publications

  • Published 10/21/2026

    Momper JD, Wang J, Bradford S, Mustich I, Johnston B, Whitson K, O'Brien M, Goldberg E, Yin DE, Townley E, Colsh K, DeYampert T, Beijer-Spell C, Wittawatmongkol O, Aziz M, Naidoo M, Ruenglerdpong S, Bekker A, Deville JG, Cruz MLS, Mathiba SR, Buchanan AM, McKenna M, Mehta R, Chandasana H, Acosta EP, Best BM, Mirochnick M, Powis KM, Shapiro DE, Clarke DF. Pharmacokinetics and safety of dolutegravir in term neonates exposed to HIV-1 (IMPAACT 2023): a phase 1, open-label, multicentre study. Lancet HIV. 2026 Oct 21. PMID: 42906569.

    Read at: PubMed

  • Published 10/3/2026

    Van Schalkwyk M, Wang J, Bekker A, Decloedt E, Theron GB, Cotton MF, Cressey TR, Wabwire D, Stotz C, Knowles K, George K, Browning R, Rungruengthanakit K, Wiesner L, Capparelli EV, Stek AM, Mirochnick M, Shapiro DE, Best BM, Eke AC. Pharmacokinetics of Efavirenz in Pregnancy and Postpartum with and Without First-line Tuberculosis Drugs: Results from IMPAACT P1026s. Clin Pharmacokinet. 2026 Oct 03. PMID: 42828638.

    Read at: PubMed

  • Published 9/23/2026

    Hughes JA, Brooks KM, Fairlie L, Best BM, Mirochnick M, Hesseling AC, Decloedt E, Pinilla M, Shapiro DE, Eke AC. Letter Reply to "Mind the Postpartum Trough: Closing the Clofazimine Exposure Gap After Delivery in Rifampicin-Resistant Tuberculosis". J Infect Dis. 2026 Sep 23; 234(3):e747-e748. PMID: 42149552.

    Read at: PubMed

  • Published 9/1/2026

    Yu Y, Brooks KM, Doncel GF, Best BM, Marzinke MA, Mirochnick M, Anderson PL, Myer L, Celum C, Heffron R, Coleman J, Davey DLJ, Zhang L, von Kleist M, Hendrix CW, Momper JD, Bies R, Scott RK. Predicting Oral HIV Pre-Exposure Prophylaxis Efficacy in Cisgender Women Across Pregnancy and Postpartum. J Clin Pharmacol. 2026 Sep; 66(9):e70278. PMID: 42687587.

    Read at: PubMed

  • Published 8/21/2026

    Barr EA, Pinilla M, Momper JD, Eke AC, Koech L, Brooks KM, Ndyanabangi V, Burchett SK, Valiyaparambil S, Mirochnick M, Stek AM, Best BM, Jeffrey R, Stotz C, Van Schalkwyk M, Browning R, Shapiro DE, Powis KM. Breastmilk transfer and infant exposure to atazanavir/ritonavir in breastfeeding women with HIV: results from IMPAACT 2026. Front Reprod Health. 2026; 8:1892081. PMID: 42666560.

    Read at: PubMed

View All 172 Publications:   View Full Profile in BUMC

Other Positions

  • Section Director, Pediatrics
    Boston University Chobanian & Avedisian School of Medicine

Websites

Education

  • University of Vermont College of Medicine, MD
  • Dickinson College, BSc

View all profiles